文献速递眼底病与葡萄膜炎

代谢组学与年龄相关性黄斑变性发病风险的关联:英国生物银行研究

Association of Metabolomics With Incidence of Age-Related Macular Degeneration: The UK Biobank Study.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2024-01-01

在英国生物银行240317名参与者的前瞻性队列中,中位随访13.69年期间5199人(2.16%)发生年龄相关性黄斑变性(AMD)。校正人口学、生活方式、多病共存、社会经济因素及AMD遗传易感性后,42种代谢物与AMD发病相关,保护性代谢物评分最高四分位者较最低四分位者AMD发病风险更低(HR=0.869,95%CI=0.803-0.940,FDR校正P=1.44×10⁻³),但代谢物未提升预测性能(AUC均为0.776)。

要点

  • 42种血清代谢物与AMD发病相关,包括VLDL相关颗粒、LDL相关颗粒、其他脂质颗粒、白蛋白和葡萄糖。
  • VLDL相关颗粒、LDL相关颗粒、三种其他脂质颗粒及白蛋白与AMD发病降低相关,葡萄糖与AMD发病风险升高相关。
  • 保护性代谢物评分最高四分位者较最低四分位者AMD发病风险更低(HR=0.869,95%CI=0.803-0.940)。

核心结论

  • 特定代谢物与AMD发病存在显著关联,涉及脂蛋白亚类、胆固醇亚型、载脂蛋白、葡萄糖和白蛋白。
  • 代谢组学未改善AMD风险预测,但某些生物标志物可能作为有前景的治疗靶点。

研究设计与样本

  • 前瞻性队列研究,纳入英国生物银行240317名参与者,评估168种代谢物与AMD发病的关联。
  • 采用Cox风险模型分析代谢物与AMD发病的关联,主成分分析提取的代谢物主成分可解释90%的变异。
  • 将主成分加入Cox模型,选取第一主成分用受试者工作特征(ROC)曲线评估模型性能。

主要发现

  • 中位随访13.69年期间,5199名(2.16%)参与者发生AMD。
  • 校正人口学、生活方式、多病共存、社会经济因素及AMD遗传易感性后,42种代谢物与AMD发病相关。
  • VLDL相关颗粒、LDL相关颗粒、三种其他脂质颗粒及白蛋白与AMD发病降低相关,葡萄糖与AMD发病风险升高相关。
  • 保护性代谢物评分最高四分位者较最低四分位者AMD发病风险更低(HR=0.869,95%CI=0.803-0.940,FDR校正P=1.44×10⁻³)。
  • 加入AMD相关代谢物后预测性能未提升(AUC均为0.776)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to identify serum metabolites associated with age-related macular degeneration (AMD) incidence and investigate whether metabolite profiles enhance AMD risk prediction. METHODS: In a prospective cohort study involving 240,317 UK Biobank participants, we assessed the associations of 168 metabolites with AMD incidence using Cox hazards models. Principal component analysis (PCA) captured 90% of the variance in metabolites. These principal components (PCs) were added to the Cox models, with the first PC selected to evaluate model performance using receiver operating characteristic (ROC) curves. RESULTS: During a median follow-up of 13.69 years, 5199 (2.16%) participants developed AMD. After accounting for demographic, lifestyle, multimorbidity, socioeconomic factors, and genetic predispositions to AMD, 42 metabolites were associated with AMD incidence. Very-low-density lipoprotein (VLDL)-related particles, low-density lipoprotein (LDL)-related particles, three additional lipids particles, and albumin were associated with decreased AMD incidence, whereas glucose increased the risk of AMD incidence. Compared to those in the lowest quartile, individuals in the highest quartile of protective metabolite scores exhibited lower risk of AMD incidence (hazard ratio [HR] = 0.869, 95% confidence interval [CI] = 0.803-0.940, false discovery rate [FDR]-adjusted P = 1.44 × 10-3). However, the AMD-associated metabolites did not enhance predictive performance (both areas under the curve [AUC] = 0.776). CONCLUSIONS: Our findings reveal significant associations between specific metabolites and AMD incidence, highlighting the roles of lipoprotein subclasses, cholesterol subtypes, apolipoproteins, glucose, and albumin. Although metabolomics did not improve risk prediction, certain biomarkers may serve as promising therapeutic targets.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Yu J, Zhang Y, Ho M, et al. Association of Metabolomics With Incidence of Age-Related Macular Degeneration: The UK Biobank Study. Invest Ophthalmol Vis Sci. 2024. PMID: 39739349. doi:10.1167/iovs.65.14.43

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。